Company Updates
KALA shareholders give the board room for another reverse split
KALA’s board may choose a ratio within the approved range. An earlier reverse split brought a temporary return to Nasdaq bid-price compliance.

KALA BIO shareholders gave the board authority on November 3 to consolidate its common shares at a ratio ranging from 1-for-2 to 1-for-300. CEO and CFO Avi Minkowitz signed the filing, which gave shareholders no selected ratio or effective date. The vote gives the board room to address a low bid price. It does not show that KALA has found a lasting fix. The company used a 1-for-50 split in May and regained bid-price compliance in June, only to receive another Nasdaq deficiency notice in August. November 3 vote filing · August 19 quarterly filing · August 28 Nasdaq notice filing
Shareholders approved the range by 14,064,372 votes to 287,744, with 107,651 abstentions. The for-and-against tally shows broad support, with abstentions reported separately. KALA’s proxy says the board can choose a single ratio and set the timing or abandon the split. That discretion may help if the stock needs a larger adjustment than the board expected. It leaves investors unable to tell how many shares they would hold after any split or how much trading liquidity would remain. November 3 vote filing · Definitive proxy
Why the previous split matters
KALA filed a charter amendment on May 7 for the earlier 1-for-50 split. It took effect May 8, and split-adjusted trading began May 11. KALA’s quarterly filing says Nasdaq notified it on June 11 that the common stock had satisfied the $1 minimum bid for 10 consecutive business days. The May split helped KALA regain compliance. That result was short-lived. The August filing says the bid fell below $1 for 30 consecutive business days from July 16 through August 26. May 7 charter filing · August 19 quarterly filing · August 28 Nasdaq notice filing
Nasdaq staff notified KALA on August 27 that it was ineligible for the ordinary 180-calendar-day compliance period because it had already completed a reverse split within the prior year. KALA said it intended to request a hearing. The company said a timely request would stay any suspension or delisting action pending a decision. The November vote filing gives no hearing outcome. Shareholder approval does not settle what Nasdaq will require or whether KALA will meet those requirements. August 28 Nasdaq notice filing · November 3 vote filing
What the board still has to decide
A split would combine outstanding shares at the chosen ratio. The proxy says KALA would pay cash in place of fractional shares and adjust the shares available under equity plans proportionately. Apart from those fractional payments, the consolidation would leave each holder’s percentage ownership and common-stock rights unchanged. A holder with fewer shares than the selected ratio could be cashed out of that position. For larger holders, the number of shares changes, while the consolidation itself raises no cash for KALA. Definitive proxy
The September 24 proxy reports 19,339,786 common shares outstanding. At the largest permitted ratio, each group of 300 existing shares would become one, with fractional shares paid in cash. The share count on the proxy record date predates this vote, so the actual post-split total would depend on the shares outstanding when the board acts. The board could choose a much smaller consolidation. The November filing gives no ratio or explanation of how the board would weigh a higher bid against fewer shares available to trade. Definitive proxy
The May split shows that a consolidation can help clear the bid threshold. The August notice shows how quickly that result can unwind. If the board proceeds again, the ratio and effective date will tell shareholders what changes in their accounts. Nasdaq’s response and trading after the split will tell them whether KALA improved its listing position. The November vote answers neither question. November 3 vote filing
Investor Chat
Loading posts…
aibio